Heartseed is a biotechnology company providing iPSC-derived cardiomyocytes for the treatment of heart failure. The company develops and commercializes cardiac regenerative medicine leveraging original technologies throughout the process of manufacturing and delivering iPSC-derived cardiac regenerative medicine, including purification, cell delivery, and iPSC production.